Finance

Lists
Why is BLSM up 3.55%?
Dive Deeper
BLSM:NASDAQ
BlossomHill Therapeutics Inc
$17.48
+3.55%
(+0.60) 1D
Oct 9, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLSM...
Open
$16.80
High
$17.77
Low
$16.68
Mkt. cap
555.60M
Avg. vol.
213.20K
Volume
0.00
52-wk high
$27.99
52-wk low
$15.25
EPS
-$2.66
No. of employees
69
Open
$16.80
High
$17.77
Low
$16.68
Mkt. cap
555.60M
Avg. vol.
213.20K
Volume
0.00
52-wk high
$27.99
52-wk low
$15.25
EPS
-$2.66
No. of employees
69
News stories
From web sources and news partners
About BlossomHill Therapeutics Inc
CEO-
Employees69
Founded2020
Headquarters-
SectorPharmaceutical industry
Websitebhtherapeutics.com
Analyst ratings
Based on 5 analysts giving stock ratings to BLSM in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for BLSM in the last 3 months.
Highest
Current $17.48
$40.00 (+128.83%)
Average
$35.40 (+102.52%)
Lowest
$30.00 (+71.62%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Reiterated
$35.00
+100.2%
09/30/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
$30.00
+71.6%
09/23/2026
Andrew Berens
Leerink Partners
Buy
Maintained
$40.00
+128.8%
09/21/2026
Michael Schmidt
Guggenheim
Buy
Maintained
$40.00
+128.8%
09/18/2026
Charles Zhu
LifeSci Capital
Buy
Maintained
$32.00
+83.1%
09/15/2026
Last report
Sep 18, 2026
Fiscal period
Q2 2026
-$8.75 / -$0.77
-1,036.36%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9.57M
12.53M
19.90M
21.36M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.88M
1.57M
2.21M
3.32M
Operating expense
11.45M
14.10M
22.11M
24.67M
Total operating expenses
11.45M
14.10M
22.11M
24.67M
Operating income
-11.45M
-14.10M
-22.11M
-24.67M
Other non operating income
-
-
-
-
EBT including unusual items
-10.48M
-13.24M
-21.01M
-23.76M
EBT excluding unusual items
-10.48M
-13.24M
-21.01M
-23.76M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.48M
-13.24M
-21.01M
-23.76M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-8.75
Interest and investment income
976.00K
859.00K
1.10M
915.00K
Interest expense
-
-
-
-
Net interest expenses
976.00K
859.00K
1.10M
915.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.37M
-14.00M
-21.98M
-24.54M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps